Contin-RUN Study: Urinary Incontinence in Female Runners
Contin-RUN
Contin-RUN Study: Prevalence and Conservative Treatment of Urinary Incontinence in Female Runners
1 other identifier
interventional
120
1 country
1
Brief Summary
This study comprises two phases, each with distinct objectives. The first phase aims to investigate the prevalence of urinary incontinence and other pelvic floor dysfunctions in Brazilian female runners through structured questionnaires. The second phase aims to evaluate and compare the effectiveness of three different exercise regimens for the treatment of urinary incontinence in female runners. The intervention groups include: a) pelvic floor muscle training combined with abdominal training, b) hypopressive abdominal exercises, and c) pelvic floor muscle training alone. The primary outcome measure is the severity of urinary incontinence, which will be assessed using the adapted 1-hour pad test and a 3-day bladder diary. Secondary outcomes include symptoms of pelvic floor dysfunction and pelvic floor muscle function. The intervention will last for 12 weeks, after which participants will be reassessed to determine which training regimen is most effective in treating urinary incontinence in female runners.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 7, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Start
First participant enrolled
September 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2026
CompletedMarch 16, 2026
September 1, 2024
1.3 years
September 7, 2024
March 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Amount of urinary leakage during running
The severity of urinary incontinence is the primary outcome of interest. The amount of urinary leakage will be assessed using a modified 1-hour pad test. The pad test will be performed on a treadmill. The participant will drink 500 ml of water in 15 minutes, wait another 15 minutes in rest, place a pre-weighed pad in her underwear, and then run continuously for 40 minutes on the treadmill at a comfortable speed of her choice. After the running period, the pad will be removed and weighed to determine the amount of urinary leakage in grams.
From enrollment to the end of the treatment at 12 weeks
Secondary Outcomes (5)
Frequency of urinary leakage
From enrollment to the end of the treatment at 12 weeks
Other pelvic floor dysfunction symptoms
From enrollment to the end of the treatment at 12 weeks
Pelvic floor muscle strength
From enrollment to the end of the treatment at 12 weeks
Pelvic floor manometry
From enrollment to the end of the treatment at 12 weeks
Impact of urinary incontinence in the quality of life
From enrollment to the end of the treatment at 12 weeks
Study Arms (3)
1PFMT + Abd Group
EXPERIMENTALParticipants in this group will perform pelvic floor muscle training in conjunction with abdominal muscle training. It is believed that abdominal contraction will lead to an increase in abdominal pressure, which will serve as additional load for pelvic floor muscle training.
AHG Group
EXPERIMENTALParticipants in this group will perform Hypopressive Abdominal Gymnastics exercises (Caufriez, 1997). It is believed that these exercises reduce the pressure on the pelvic floor muscles and help tone this musculature without causing harm.
PFMT Group
ACTIVE COMPARATORParticipants of PFMT group will perform specific exercises for the pelvic floor muscles, with maximum contraction and without involvement of other muscle groups. This arm is considered the control group because it is the treatment that has been proven to effectively treat urinary incontinence, as demonstrated in over 50 clinical trials.
Interventions
Participants in this group will undergo 12 weeks of in-person training, with supervision by a specialist physical therapist, in groups of up to four women. The training will take place after an initial evaluation and will consist of 24 sessions, held twice a week. Exercises will target both the pelvic floor muscles and the abdominal muscles. The exercises will be divided into three phases, with progressively increasing difficulty each month. The progression will be achieved by increasing the load, the number of repetitions, and the complexity of the exercises.
Participants in this group will perform Hypopressive Abdominal Gymnastics exercises as proposed by Marcel Caufriez (1997). The training will last 12 weeks and be conducted in person, with supervision by a specialist physical therapist, in groups of up to four women. The training will take place after an initial evaluation and will consist of 24 sessions, held twice a week. The exercises will be divided into three phases, with progressively increasing difficulty each month. Progression will be achieved by changing body positions, increasing the number of repetitions, and extending the duration of inspiratory apnea.
Participants in this group will undergo 12 weeks of in-person training, supervised by a specialist physical therapist, in groups of up to four women. Specific exercises targeting the pelvic floor muscles will be performed, with voluntary and maximal contractions, without involving other muscle groups. The exercises will be divided into three phases, with progressively increasing difficulty each month. Progression will be achieved by increasing the load (transitioning from gravitational to antigravitational positions), increasing the number of repetitions, and combining sustained and rapid contractions to enhance the difficulty of execution.
Eligibility Criteria
You may qualify if:
- Participants must have been running for at least six months
- Run at least 15 kilometers per week,
- Have no injuries that have prevented them from running for more than three weeks in the past six months
- Experience involuntary urinary leakage during running
- The women must have a pelvic floor muscle strength of ≥ 2 on the modified Oxford scale
You may not qualify if:
- Having a diagnosed neuromuscular disease that affects bladder function
- Having undergone previous pelvic or perineal surgeries for the correction of pelvic floor dysfunctions
- Having previously received physical therapy for the treatment of pelvic floor dysfunctions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Benjamin Constant St, 1286
Uberlândia, Minas Gerais, 38400-678, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor Ana Paula M. Resende, PT, PhD, Principal Investigator
Study Record Dates
First Submitted
September 7, 2024
First Posted
September 19, 2024
Study Start
September 20, 2024
Primary Completion
January 10, 2026
Study Completion
March 10, 2026
Last Updated
March 16, 2026
Record last verified: 2024-09